JP2018518460A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018518460A5 JP2018518460A5 JP2017556593A JP2017556593A JP2018518460A5 JP 2018518460 A5 JP2018518460 A5 JP 2018518460A5 JP 2017556593 A JP2017556593 A JP 2017556593A JP 2017556593 A JP2017556593 A JP 2017556593A JP 2018518460 A5 JP2018518460 A5 JP 2018518460A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- mammal
- body weight
- weight
- composition comprises
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 11
- 239000000203 mixture Substances 0.000 claims 10
- 241000124008 Mammalia Species 0.000 claims 5
- 230000037396 body weight Effects 0.000 claims 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- 206010064930 age-related macular degeneration Diseases 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 208000002780 macular degeneration Diseases 0.000 claims 2
- 235000006010 Bixa orellana Nutrition 0.000 claims 1
- 244000017106 Bixa orellana Species 0.000 claims 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims 1
- ZVKOASAVGLETCT-UOGKPENDSA-N Norbixin Chemical compound OC(=O)/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C(O)=O ZVKOASAVGLETCT-UOGKPENDSA-N 0.000 claims 1
- JERYLJRGLVHIEW-UENHKZIGSA-N Norbixin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)C=CC=CC=CC(=O)O JERYLJRGLVHIEW-UENHKZIGSA-N 0.000 claims 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 claims 1
- 208000027073 Stargardt disease Diseases 0.000 claims 1
- 229930003268 Vitamin C Natural products 0.000 claims 1
- 229930003427 Vitamin E Natural products 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- ZVKOASAVGLETCT-UOAMSCJGSA-N all-trans norbixin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)C=CC=C(/C)C=CC(=O)O ZVKOASAVGLETCT-UOAMSCJGSA-N 0.000 claims 1
- 239000001670 anatto Substances 0.000 claims 1
- 235000012665 annatto Nutrition 0.000 claims 1
- 235000012978 bixa orellana Nutrition 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000037406 food intake Effects 0.000 claims 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 239000002417 nutraceutical Substances 0.000 claims 1
- 235000021436 nutraceutical agent Nutrition 0.000 claims 1
- 230000003711 photoprotective effect Effects 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 230000005855 radiation Effects 0.000 claims 1
- 210000001525 retina Anatomy 0.000 claims 1
- 239000000790 retinal pigment Substances 0.000 claims 1
- 238000001228 spectrum Methods 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- 235000019154 vitamin C Nutrition 0.000 claims 1
- 239000011718 vitamin C Substances 0.000 claims 1
- 235000019165 vitamin E Nutrition 0.000 claims 1
- 229940046009 vitamin E Drugs 0.000 claims 1
- 239000011709 vitamin E Substances 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
- 235000016804 zinc Nutrition 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1553957 | 2015-04-30 | ||
| FR1553957A FR3035589B1 (fr) | 2015-04-30 | 2015-04-30 | Composition pour la protection des cellules de l'epithelium pigmentaire retinien |
| PCT/FR2016/051001 WO2016174360A1 (fr) | 2015-04-30 | 2016-04-28 | Composition contenant de la norbixine pour la protection des cellules de l'epithelium pigmentaire retinien |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018518460A JP2018518460A (ja) | 2018-07-12 |
| JP2018518460A5 true JP2018518460A5 (https=) | 2019-04-25 |
| JP6660401B2 JP6660401B2 (ja) | 2020-03-11 |
Family
ID=53758384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017556593A Active JP6660401B2 (ja) | 2015-04-30 | 2016-04-28 | 網膜色素上皮の細胞を保護するためのノルビキシン含有組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10314804B2 (https=) |
| EP (1) | EP3288551B1 (https=) |
| JP (1) | JP6660401B2 (https=) |
| KR (1) | KR102575312B1 (https=) |
| CN (1) | CN107708685B (https=) |
| AU (1) | AU2016256637A1 (https=) |
| BR (1) | BR112017023264A2 (https=) |
| CA (1) | CA2984405C (https=) |
| ES (1) | ES2752061T3 (https=) |
| FR (1) | FR3035589B1 (https=) |
| IL (1) | IL255276A0 (https=) |
| MX (1) | MX376021B (https=) |
| PL (1) | PL3288551T3 (https=) |
| RU (1) | RU2715889C2 (https=) |
| WO (1) | WO2016174360A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3078252B1 (fr) * | 2018-02-28 | 2020-08-14 | Biophytis | Phytoecdysones pour leur utilisation dans la prevention de la perte de force musculaire lors d’une immobilisation |
| JP7355394B2 (ja) | 2018-05-03 | 2023-10-03 | エル．イー．エー．エフ． ホールディングス グループ エルエルシー | カロテノイド組成物およびその使用 |
| KR20200134935A (ko) | 2019-05-24 | 2020-12-02 | (주)비지엔케어 | 커큐민을 유효성분으로 포함하는 인간 망막색소상피세포 증식 개선용 약학 조성물 |
| WO2021091862A1 (en) * | 2019-11-06 | 2021-05-14 | L.E.A.F. Holdings Group Llc | Carotenoid compositions and uses thereof |
| FR3105790B1 (fr) | 2019-12-26 | 2022-01-14 | Biophytis | Composés chimiques ciblant l’œil et leur utilisation dans le traitement de maladies oculaires |
| KR20210008884A (ko) | 2021-01-08 | 2021-01-25 | (주)비지엔케어 | 커큐민을 유효성분으로 포함하는 인간 망막색소상피세포 증식 개선용 조성물 및 기능성 식품 조성물 |
| TWI894483B (zh) * | 2022-08-24 | 2025-08-21 | 鼎赫生物科技股份有限公司 | 一種組合物用於治療眼睛疾病之醫藥品用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1154172A (fr) | 1955-07-05 | 1958-04-03 | Rollei Werke Franke Heidecke | étui de protection pour appareils photographiques |
| WO2001085183A2 (en) * | 2000-05-08 | 2001-11-15 | N.V. Nutricia | Preparation for the prevention and treatment of ocular disorders |
| EP1635842A4 (en) * | 2003-06-20 | 2007-04-04 | Alcon Inc | TREATMENT OF AMD WITH A COMBINATION OF INGREDIENTS |
| US7887847B2 (en) * | 2004-05-08 | 2011-02-15 | Paul Jr Edward L | Nutritional supplement for treatment of ocular diseases |
| US20060134226A1 (en) * | 2004-11-16 | 2006-06-22 | Todd Leonard | Compositions useful to treat ocular neovascular diseases and macular degeneration |
| JP2008179632A (ja) * | 2006-12-29 | 2008-08-07 | Fuji Chem Ind Co Ltd | 抗酸化剤 |
| JP5550854B2 (ja) * | 2009-06-10 | 2014-07-16 | 理研ビタミン株式会社 | 一重項酸素消去剤 |
| FR2947173B1 (fr) | 2009-06-25 | 2012-01-27 | Inst Biophytis | Composition alimentaire destinee a la protection solaire |
| JP2012097003A (ja) * | 2010-10-29 | 2012-05-24 | Gifu City | ビキシン誘導体及び細胞保護剤 |
| FR2975008B1 (fr) | 2011-05-13 | 2014-03-07 | Inst Biophytis | Utilisation de composes et composition pour le traitement de la degenerescence maculaire liee a l'age (dmla) |
-
2015
- 2015-04-30 FR FR1553957A patent/FR3035589B1/fr not_active Expired - Fee Related
-
2016
- 2016-04-28 CA CA2984405A patent/CA2984405C/fr active Active
- 2016-04-28 BR BR112017023264-2A patent/BR112017023264A2/pt not_active Application Discontinuation
- 2016-04-28 PL PL16722319T patent/PL3288551T3/pl unknown
- 2016-04-28 JP JP2017556593A patent/JP6660401B2/ja active Active
- 2016-04-28 US US15/570,720 patent/US10314804B2/en active Active
- 2016-04-28 MX MX2017013918A patent/MX376021B/es active IP Right Grant
- 2016-04-28 ES ES16722319T patent/ES2752061T3/es active Active
- 2016-04-28 RU RU2017141462A patent/RU2715889C2/ru active
- 2016-04-28 EP EP16722319.7A patent/EP3288551B1/fr active Active
- 2016-04-28 KR KR1020177034255A patent/KR102575312B1/ko active Active
- 2016-04-28 AU AU2016256637A patent/AU2016256637A1/en not_active Abandoned
- 2016-04-28 WO PCT/FR2016/051001 patent/WO2016174360A1/fr not_active Ceased
- 2016-04-28 CN CN201680037407.9A patent/CN107708685B/zh active Active
-
2017
- 2017-10-26 IL IL255276A patent/IL255276A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018518460A5 (https=) | ||
| RU2017141462A (ru) | Композиция, содержащая норбиксин, для защиты клеток пигментного эпителия сетчатки | |
| JP2015516496A5 (https=) | ||
| RU2672575C2 (ru) | Лечение рака головного мозга | |
| SG10201903210WA (en) | Sunitinib Formulations and Methods for Use Thereof in Treatment of Ocular Disorders | |
| JP5897592B2 (ja) | 葉酸−ラミプリルの組合せ：細胞保護性、神経保護性、および網膜保護性の眼科用組成物 | |
| HRP20161718T1 (hr) | Pripravak bixa orellana za liječenje makularne degeneracije | |
| RU2017112930A (ru) | Офтальмологические составы для доставки лекарств и защиты переднего отдела глаза | |
| Xin et al. | Ophthalmic drops with nanoparticles derived from a natural product for treating age-related macular degeneration | |
| MX2020010502A (es) | Agentes farmacológicos para el tratamiento de enfermedades oculares. | |
| JP2016516773A5 (https=) | ||
| AR062395A1 (es) | Uso de derivados del 2.5-dihidroxibenceno para el tratamiento de enfermedades oculares | |
| JP2018529666A5 (https=) | ||
| JP2017527600A5 (https=) | ||
| HRP20190561T1 (hr) | Postupci liječenja bolesti oka povezanih s upalom i vaskularnom proliferacijom | |
| JP2018524306A5 (https=) | ||
| JP2008540528A5 (https=) | ||
| JP2019513812A5 (https=) | ||
| HRP20250123T1 (hr) | Spojevi za liječenje bolesti vezanih s lipofuscinom | |
| HRP20210418T1 (hr) | Liječenje s syd985 pacijenata s rakom koji ne reagira na t-dm1 | |
| JP2018529747A5 (https=) | ||
| JP2021138710A5 (https=) | ||
| WO2016122288A3 (ko) | 베르베논 유도체 및 재관류 치료제를 포함하는 뇌혈관 질환, 동맥경화증 또는 심혈관 질환 치료 또는 예방용 병용 제제 | |
| JP2012532197A5 (https=) | ||
| ES2860767T3 (es) | Mirabegrón para el tratamiento de enfermedades retinianas |